starting dose for tirzepatide Dosage Guide and Chart Weight Loss Tirzepatide dosage chart for weight

Semaglutide, on the other hand, is a GLP-1 receptor agonist, which means it only targets one hormone involved in regulating blood sugar and appetite

* Correspondence: Richard M

The most common are nausea, vomiting, diarrhea, and constipation, usually worst when the dose increases

These include: Nausea (very common, may affect more than 1 in 10 people) Diarrhoea (very common) Vomiting (common, may affect up to 1 in 10 people) Constipation and abdominal pain (common) Decreased appetite (very common) These gastrointestinal symptoms typically diminish over time as the body adjusts to the medication

However, that could change